Skip to main content
. 2019 Jan 4;41(1):65–73. doi: 10.1007/s11096-018-0775-9

Table 4.

Patient and service delivery related outcomes

Comparator group (N = 130) Intervention group (N = 130) p Value
Duration of the PTWR (e.g., time spent by PTWR team by with each patient) (mean, SD) minutes 23.8 ± 8.9 20.7 ± 9.9 < 0.008
Ward pharmacist review (minimum of one pharmacy review by ward pharmacist during stay) 116 (89.2%) 108 (83%) 0.26*
Medication action plan (MAP) completed by pharmacist during admission 112 (86.2%) 104 (80%) 0.29*
Length of stay (days) Median (IQR) 4 (2–7) 4 (2–7) 0.34
Discharge medication record (DMR) prepared for patient and patient counselled by clinical pharmacist 80 (62%) 73 (56.2%) 0.34*
Unplanned readmission < 30 days 15 (11.5%) 11 (8.5%) 0.43*

Statistical tests: * Chi squared, † student’s T-test

HHS Vulnerability Disclosure